ClinVar Miner

Submissions for variant NM_002225.5(IVD):c.932C>T (p.Ala311Val) (rs28940889)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000080003 SCV000233053 pathogenic not provided 2014-08-20 criteria provided, single submitter clinical testing
GeneDx RCV000080003 SCV000238934 pathogenic not provided 2018-03-29 criteria provided, single submitter clinical testing The A314V missense variant in the IVD gene has been reported previously in association with isovaleric acidemia (IVA) (Ensenauer et al., 2004). This variant has been found in a homozygous or compound heterozygous state with another IVD variant in approximately two-thirds of newborns with IVA diagnosed by newborn screening. Thus far, all of the newborns harboring A314V, including compound heterozygotes for this variant, have a mild biochemical phenotype and have remained asymptomatic with no or limited treatment. Based on the available evidence, we consider A314V to be a pathogenic variant.
Illumina Clinical Services Laboratory,Illumina RCV000003749 SCV000390865 pathogenic Isovaleryl-CoA dehydrogenase deficiency 2017-04-27 criteria provided, single submitter clinical testing The IVD c.941C>T (p.Ala314Val) missense variant, also known as p.Ala282Val, is well-described in the literature as a common variant associated with isovaleric acidemia (IVA). Across a selection of the available literature, the p.Ala314Val variant has been identified in a homozygous state in six patients and in a compound heterozygous state in nine patients (Mohsen et al. 1998; Ensenauer et al. 2004; Lambrecht et al. 2015). The patients all presented with a very mild or asymptomatic clinical phenotype. One of the homozygous individuals also presented with Angelmann syndrome (Lambrecht et al. 2015). The p.Ala314Val variant was absent from 100 controls and is reported at a frequency of 0.00118 in the European (non-Finnish) population of the Exome Aggregation Consortium. Functional studies in patient cells and E. coli demonstrated that the variant resulted in reduced enzyme activity compared to wild type, ranging from no activity to 19% activity (Mohsen et al. 1998; Ensenauer et al. 2004). The enzyme also exhibits diminished thermal stability (Nasser et al. 2004). Based on the evidence, the p.Ala314Val variant is classified as pathogenic for isovaleric acidemia with an associated mild clinical presentation. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics RCV000080003 SCV000511591 pathogenic not provided 2017-01-11 criteria provided, single submitter clinical testing
Fulgent Genetics,Fulgent Genetics RCV000003749 SCV000611275 pathogenic Isovaleryl-CoA dehydrogenase deficiency 2017-05-18 criteria provided, single submitter clinical testing
Invitae RCV000003749 SCV000631895 pathogenic Isovaleryl-CoA dehydrogenase deficiency 2020-10-25 criteria provided, single submitter clinical testing This sequence change replaces alanine with valine at codon 314 of the IVD protein (p.Ala314Val). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs28940889, ExAC 0.1%). This variant is frequently detected in individuals identified from NBS or asymptomatic individuals with mild elevations of isovaleric acidemia-related metabolites and residual IVD enzyme activity (PMID: 15486829). It has been reported as homozygous or in combination with other IVD variants in individuals affected with isovaleric acidemia (PMID: 15486829, 9665741, 27904153). This variant is also known as p.Ala282Val in the literature. ClinVar contains an entry for this variant (Variation ID: 10060). Experimental studies have shown that this variant caused partial reduction of enzyme activity in vitro (PMID: 9665741). For these reasons, this variant has been classified as Pathogenic.
Baylor Genetics RCV000003749 SCV001163388 pathogenic Isovaleryl-CoA dehydrogenase deficiency criteria provided, single submitter clinical testing
Myriad Women's Health, Inc. RCV000003749 SCV001194070 pathogenic Isovaleryl-CoA dehydrogenase deficiency 2019-11-13 criteria provided, single submitter clinical testing NM_002225.3(IVD):c.941C>T(A314V, aka A311V) is classified as pathogenic in the context of isovaleric acidemia. Please note that individuals with the A314V variant may have a mild form of isovaleric acidemia or may be asymptomatic. Sources cited for classification include the following: PMID 15486829, 15337167 and 9665741. Classification of NM_002225.3(IVD):c.941C>T(A314V, aka A311V) is based on the following criteria: This is a well-established pathogenic variant in the literature that has been observed more frequently in patients with clinical diagnoses than in healthy populations. Please note: this variant was assessed in the context of healthy population screening.
Institute of Human Genetics, University of Leipzig Medical Center RCV000003749 SCV001428919 pathogenic Isovaleryl-CoA dehydrogenase deficiency 2018-01-11 criteria provided, single submitter clinical testing
Ambry Genetics RCV001266807 SCV001444986 likely pathogenic Inborn genetic diseases 2020-01-07 criteria provided, single submitter clinical testing
Greenwood Genetic Center Diagnostic Laboratories,Greenwood Genetic Center RCV000080003 SCV001468012 pathogenic not provided 2020-10-13 criteria provided, single submitter clinical testing
OMIM RCV000003749 SCV000023914 pathogenic Isovaleryl-CoA dehydrogenase deficiency 2004-12-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.